propionylcarnitine has been researched along with pentoxifylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiatt, WR | 1 |
| Doggrell, SA | 1 |
| Chen, Z; Jin, B; Li, J; Li, K; Li, L; Liu, C; Luo, T; Yang, B; Zhang, J; Zhang, X; Zheng, Q | 1 |
2 review(s) available for propionylcarnitine and pentoxifylline
| Article | Year |
|---|---|
New treatment options in intermittent claudication: the US experience.
Topics: Arginine; Carnitine; Cilostazol; Endothelial Growth Factors; Exercise Therapy; Humans; Intermittent Claudication; Multicenter Studies as Topic; Nafronyl; Pentoxifylline; Phosphodiesterase Inhibitors; Prostaglandins; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Antagonists; Tetrazoles; United States | 2001 |
Pharmacotherapy of intermittent claudication.
Topics: Animals; Anticoagulants; Cardiotonic Agents; Carnitine; Cilostazol; Humans; Intermittent Claudication; Nafronyl; Nitric Oxide; Pentoxifylline; Platelet Aggregation Inhibitors; Tetrazoles; Vasodilator Agents | 2001 |
1 trial(s) available for propionylcarnitine and pentoxifylline
| Article | Year |
|---|---|
A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
Topics: Administration, Oral; Aged; Carnitine; Double-Blind Method; Humans; Intermittent Claudication; Middle Aged; Pentoxifylline; Peripheral Arterial Disease; Treatment Outcome; Walking | 2013 |